Review
doi: 10.1016/0006-2952(91)90441-7.
Mechanisms of the protective effects of transforming growth factor-beta in reperfusion injury
Affiliations
- PMID: 1930256
- DOI: 10.1016/0006-2952(91)90441-7
Item in Clipboard
Review
Mechanisms of the protective effects of transforming growth factor-beta in reperfusion injury
Biochem Pharmacol.
.
Abstract
TGF-beta appears to be an important regulatory peptide in cellular physiology. Although all of its actions are not presently known, TGF-beta functions as a cell-switching molecule. In the case of ischemia-reperfusion states, TGF-beta has been shown to exert remarkably effective protective effects. These effects appear to pertain to preservation of endothelial function, particularly to maintenance of EDRF formation by the endothelium. The endothelial protection may be related to actions of TGF-beta opposing the endothelial-destabilizing actions of both TNF and superoxide radicals. However, other important mechanisms will undoubtedly be brought to light with further study of TGF-beta in these situations.
Similar articles
-
Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion.Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1018-22. doi: 10.1073/pnas.90.3.1018. Proc Natl Acad Sci U S A. 1993. PMID: 8381531 Free PMC article.
-
Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.Annu Rev Pharmacol Toxicol. 1993;33:71-90. doi: 10.1146/annurev.pa.33.040193.000443. Annu Rev Pharmacol Toxicol. 1993. PMID: 8494355 Review.
-
Transforming growth factor-beta 1 inhibits postischemic increases in splanchnic vascular resistance.Biotechnol Ther. 1992;3(3-4):91-100. Biotechnol Ther. 1992. PMID: 1303730
-
Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia.FASEB J. 1991 Apr;5(7):2029-34. doi: 10.1096/fasebj.5.7.2010056. FASEB J. 1991. PMID: 2010056 Review.
-
Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.J Cardiovasc Pharmacol. 1991 Jul;18(1):95-105. doi: 10.1097/00005344-199107000-00013. J Cardiovasc Pharmacol. 1991. PMID: 1719297
Cited by
-
Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion.Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1018-22. doi: 10.1073/pnas.90.3.1018. Proc Natl Acad Sci U S A. 1993. PMID: 8381531 Free PMC article.
-
Role of cytokines in myocardial ischemia and reperfusion.Mediators Inflamm. 1997;6(3):175-83. doi: 10.1080/09629359791668. Mediators Inflamm. 1997. PMID: 18472818 Free PMC article.
-
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.Signal Transduct Target Ther. 2024 Jan 8;9(1):12. doi: 10.1038/s41392-023-01688-x. Signal Transduct Target Ther. 2024. PMID: 38185705 Free PMC article. Review.
-
Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1.J Clin Invest. 1992 Nov;90(5):2056-62. doi: 10.1172/JCI116087. J Clin Invest. 1992. PMID: 1430228 Free PMC article.
-
Inflammation in traumatic brain injury: role of cytokines and chemokines.Neurochem Res. 1998 Mar;23(3):329-40. doi: 10.1023/a:1022453332560. Neurochem Res. 1998. PMID: 9482245 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
